Literature DB >> 26518444

The Genetic Challenges and Opportunities in Advanced Heart Failure.

Fady Hannah-Shmouni1, Sara B Seidelmann1, Sandra Sirrs2, Arya Mani3, Daniel Jacoby4.   

Abstract

The causes of heart failure are diverse. Inherited causes represent an important clinical entity and can be divided into 2 major categories: familial and metabolic cardiomyopathies. The distinct features that might be present in early disease states can become broadly overlapping with other diseases, such as in the case of inherited cardiomyopathies (ie, familial hypertrophic cardiomyopathy or mitochondrial diseases). In this review article, we focus on genetic issues related to advanced heart failure. Because of the emerging importance of this topic and its breadth, we sought to focus our discussion on the known genetic forms of heart failure syndromes, genetic testing, and newer data on pharmacogenetics and therapeutics in the treatment of heart failure, to primarily encourage clinicians to place a priority on the diagnosis and treatment of these potentially treatable conditions.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26518444      PMCID: PMC5423787          DOI: 10.1016/j.cjca.2015.07.735

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  145 in total

1.  Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.

Authors:  M H Gollob; M S Green; A S Tang; T Gollob; A Karibe; A S Ali Hassan ; F Ahmad; R Lozado; G Shah; L Fananapazir; L L Bachinski; R Roberts; A S Hassan
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

2.  The varying evolution of Friedreich's ataxia cardiomyopathy.

Authors:  F Casazza; M Morpurgo
Journal:  Am J Cardiol       Date:  1996-04-15       Impact factor: 2.778

Review 3.  Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something new.

Authors:  Jasmine A Talameh; Howard L McLeod; Kirkwood F Adams; J Herbert Patterson
Journal:  J Card Fail       Date:  2012-02-02       Impact factor: 5.712

4.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Authors:  Dingding Xiong; Huamei He; Jeanne James; Chonan Tokunaga; Corey Powers; Yan Huang; Hanna Osinska; Jeffrey A Towbin; Enkhsaikhan Purevjav; James A Balschi; Sabzali Javadov; Francis X McGowan; Arnold W Strauss; Zaza Khuchua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

5.  Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment.

Authors:  Thomas Rau; Roland Heide; Klaus Bergmann; Henrike Wuttke; Ulrike Werner; Nico Feifel; Thomas Eschenhagen
Journal:  Pharmacogenetics       Date:  2002-08

6.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors:  Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

Review 7.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

Authors:  Barry J Maron; Bernard R Chaitman; Michael J Ackerman; Antonio Bayés de Luna; Domenico Corrado; Jane E Crosson; Barbara J Deal; David J Driscoll; N A Mark Estes; Claudio Gil S Araújo; David H Liang; Matthew J Mitten; Robert J Myerburg; Antonio Pelliccia; Paul D Thompson; Jeffrey A Towbin; Steven P Van Camp
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

Review 8.  Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.

Authors:  A D Struthers
Journal:  J Card Fail       Date:  1996-03       Impact factor: 5.712

9.  Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy.

Authors:  E Arbustini; M Diegoli; R Fasani; M Grasso; P Morbini; N Banchieri; O Bellini; B Dal Bello; A Pilotto; G Magrini; C Campana; P Fortina; A Gavazzi; J Narula; M Viganò
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Inhibition of miR-25 improves cardiac contractility in the failing heart.

Authors:  Christine Wahlquist; Dongtak Jeong; Agustin Rojas-Muñoz; Changwon Kho; Ahyoung Lee; Shinichi Mitsuyama; Alain van Mil; Woo Jin Park; Joost P G Sluijter; Pieter A F Doevendans; Roger J Hajjar; Mark Mercola
Journal:  Nature       Date:  2014-03-12       Impact factor: 49.962

View more
  3 in total

1.  Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults.

Authors:  Sara B Seidelmann; Emily Smith; Lakshman Subrahmanyan; Daniel Dykas; Maen D Abou Ziki; Bani Azari; Fady Hannah-Shmouni; Yuexin Jiang; Joseph G Akar; Mark Marieb; Daniel Jacoby; Allen E Bale; Richard P Lifton; Arya Mani
Journal:  Circ Cardiovasc Genet       Date:  2017-02

2.  Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.

Authors:  Mălina Suciu-Petrescu; Anamaria Truta; Mihai Domnutiu Suciu; Adrian Pavel Trifa; Denisa Petrescu; Horia Ștefan Roșianu; Octavia Sabin; Daciana Elena Popa; Antonia Eugenia Macarie; Ștefan Cristian Vesa; Anca Dana Buzoianu
Journal:  Exp Ther Med       Date:  2021-04-28       Impact factor: 2.447

3.  Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications.

Authors:  Francesca Girolami; Giulia Frisso; Matteo Benelli; Lia Crotti; Maria Iascone; Ruggiero Mango; Cristina Mazzaccara; Kalliope Pilichou; Eloisa Arbustini; Benedetta Tomberli; Giuseppe Limongelli; Cristina Basso; Iacopo Olivotto
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2018-01       Impact factor: 2.160

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.